These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
214 related items for PubMed ID: 7688654
1. Lymphoproliferative disorder of granular lymphocytes associated with severe neutropenia. Response to granulocyte colony-stimulating factor. Cooper DL, Henderson-Bakas M, Berliner N. Cancer; 1993 Sep 01; 72(5):1607-11. PubMed ID: 7688654 [Abstract] [Full Text] [Related]
2. Eosinophilia resulting from administration of recombinant granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in a patient with T-gamma lymphoproliferative disease. Gonzales-Chambers R, Rosenfeld C, Winkelstein A, Dameshek L. Am J Hematol; 1991 Feb 01; 36(2):157-9. PubMed ID: 2012068 [Abstract] [Full Text] [Related]
3. Granulocyte and granulocyte-macrophage colony-stimulating factors for treatment of neutropenia in glycogen storage disease type Ib. Schroten H, Roesler J, Breidenbach T, Wendel U, Elsner J, Schweitzer S, Zeidler C, Burdach S, Lohmann-Matthes ML, Wahn V. J Pediatr; 1991 Nov 01; 119(5):748-54. PubMed ID: 1719175 [Abstract] [Full Text] [Related]
4. The role of colony-stimulating factors and granulocyte transfusion in treatment options for neutropenia in children with cancer. Liang DC. Paediatr Drugs; 2003 Nov 01; 5(10):673-84. PubMed ID: 14510625 [Abstract] [Full Text] [Related]
5. Lack of benefit of granulocyte macrophage or granulocyte colony stimulating factor in patients with febrile neutropenia. Siddiqui T, Burney IA, Kakepoto GN, Khurshid M, Salam A, Smego RA. J Pak Med Assoc; 2002 May 01; 52(5):206-10. PubMed ID: 12174492 [Abstract] [Full Text] [Related]
6. Stimulation of myelopoiesis in chronic lymphocytic leukemia and in other lymphoproliferative disorders by recombinant human granulocyte-macrophage colony-stimulating factor. Vadhan-Raj S, Velasquez WS, Butler JJ, LeMaistre A, Lepe-Zuniga J, Keating MJ, Koller CA, Gutterman JU. Am J Hematol; 1990 Mar 01; 33(3):189-97. PubMed ID: 2405649 [Abstract] [Full Text] [Related]
7. Clinical features of myelokathexis and treatment with hematopoietic cytokines: a case report of two patients and review of the literature. Hord JD, Whitlock JA, Gay JC, Lukens JN. J Pediatr Hematol Oncol; 1997 Mar 01; 19(5):443-8. PubMed ID: 9329467 [Abstract] [Full Text] [Related]
11. Treatment of chronic neutropenia associated with large granular lymphocytosis with cyclosporine A and filgrastim. Jakubowski A, Winton EF, Gencarelli A, Gabrilove J. Am J Hematol; 1995 Dec 01; 50(4):288-91. PubMed ID: 7485104 [Abstract] [Full Text] [Related]
12. Effects of a formulary change from granulocyte colony-stimulating factor to granulocyte-macrophage colony-stimulating factor on outcomes in patients treated with myelosuppressive chemotherapy. Wong SF, Chan HO. Pharmacotherapy; 2005 Mar 01; 25(3):372-8. PubMed ID: 15843284 [Abstract] [Full Text] [Related]
13. Granulocyte colony-stimulating factor (rh G-CSF) as an adjunct to interferon alpha therapy of neutropenic patients with hairy cell leukemia. Lorber C, Willfort A, Ohler L, Jäger U, Schwarzinger I, Lechner K, Geissler K. Ann Hematol; 1993 Jul 01; 67(1):13-6. PubMed ID: 7687471 [Abstract] [Full Text] [Related]
14. Low doses of colony-stimulating factors lead to resolution of neutropenia in cancer patients through increased levels of dihydrofolate reductase. Iqbal MP, Burney IA. Pak J Pharm Sci; 2014 Mar 01; 27(2):245-8. PubMed ID: 24577909 [Abstract] [Full Text] [Related]
16. 2010 update of EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphoproliferative disorders and solid tumours. Aapro MS, Bohlius J, Cameron DA, Dal Lago L, Donnelly JP, Kearney N, Lyman GH, Pettengell R, Tjan-Heijnen VC, Walewski J, Weber DC, Zielinski C, European Organisation for Research and Treatment of Cancer. Eur J Cancer; 2011 Jan 01; 47(1):8-32. PubMed ID: 21095116 [Abstract] [Full Text] [Related]
17. Randomized placebo-controlled trial of granulocyte-macrophage colony-stimulating factor in patients with chemotherapy-related febrile neutropenia. Vellenga E, Uyl-de Groot CA, de Wit R, Keizer HJ, Löwenberg B, ten Haaft MA, de Witte TJ, Verhagen CA, Stoter GJ, Rutten FF, Mulder NH, Smid WM, de Vries EG. J Clin Oncol; 1996 Feb 01; 14(2):619-27. PubMed ID: 8636779 [Abstract] [Full Text] [Related]
18. In vitro and in vivo effects of granulocyte colony-stimulating factor on neutrophils in glycogen storage disease type 1B: granulocyte colony-stimulating factor therapy corrects the neutropenia and the defects in respiratory burst activity and Ca2+ mobilization. McCawley LJ, Korchak HM, Douglas SD, Campbell DE, Thornton PS, Stanley CA, Baker L, Kilpatrick L. Pediatr Res; 1994 Jan 01; 35(1):84-90. PubMed ID: 7510873 [Abstract] [Full Text] [Related]
20. Effects of granulocyte and granulocyte-macrophage colony-stimulating factors in a neutropenic murine model of trichosporonosis. Muranaka H, Suga M, Nakagawa K, Sato K, Gushima Y, Ando M. Infect Immun; 1997 Aug 01; 65(8):3422-9. PubMed ID: 9234807 [Abstract] [Full Text] [Related] Page: [Next] [New Search]